{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T19:00:05Z","timestamp":1776106805554,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T00:00:00Z","timestamp":1526947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Fondazione Arianna Anticoagulazione"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s11739-018-1877-z","type":"journal-article","created":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T23:10:48Z","timestamp":1526944248000},"page":"1051-1058","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Management of major bleeding and outcomes in patients treated with direct oral anticoagulants: results from the START-Event registry"],"prefix":"10.1007","volume":"13","author":[{"given":"Sophie","family":"Testa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Ageno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia","family":"Antonucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossella","family":"Morandini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Beyer-Westendorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Paciaroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Righini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piera","family":"Sivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Verhamme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittorio","family":"Pengo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Poli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gualtiero","family":"Palareti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,22]]},"reference":[{"key":"1877_CR1","doi-asserted-by":"publisher","first-page":"e44S","DOI":"10.1378\/chest.11-2292","volume":"141","author":"W Ageno","year":"2012","unstructured":"Ageno W, Gallus AS, Wittkowsky A, ACCP et al (2012) Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141:e44S\u2013e88S","journal-title":"Chest"},{"key":"1877_CR2","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","volume":"361","author":"SJ Connolly","year":"2009","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S, RE-LY Steering Committee and Investigators et al (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139\u20131151","journal-title":"N Engl J Med"},{"key":"1877_CR3","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J et al (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365:883\u2013891","journal-title":"N Engl J Med"},{"key":"1877_CR4","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"CB Granger","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ, ARISTOTLE Committees Investigators et al (2011) Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365:981\u2013992","journal-title":"N Engl J Med"},{"key":"1877_CR5","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","volume":"369","author":"RP Giugliano","year":"2013","unstructured":"Giugliano RP, Ruff CT, Braunwald E, ENGAGE AF-TIMI 48 Investigators et al (2013) Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 369:2093\u20132104","journal-title":"N Engl J Med"},{"key":"1877_CR6","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","volume":"383","author":"CT Ruff","year":"2014","unstructured":"Ruff CT, Giugliano RP, Braunwald E et al (2014) Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 383:955\u2013962","journal-title":"Lancet"},{"key":"1877_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/0003088-200948010-00001","volume":"48","author":"BI Eriksson","year":"2009","unstructured":"Eriksson BI, Quinlan DJ, Weitz JI (2009) Comparative pharmacodynamics and pharmacokinetics of oral direct thrombin and factor xa inhibitors in development. Clin Pharmacokinet 48:1\u201322","journal-title":"Clin Pharmacokinet"},{"key":"1877_CR8","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s11739-017-1628-6","volume":"1","author":"D Prisco","year":"2017","unstructured":"Prisco D, Ageno W, Becattini C et al (2017) Italian intersociety consensus on DOAC use in internal medicine. Intern Emerg Med 1:387\u2013406","journal-title":"Intern Emerg Med"},{"key":"1877_CR9","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1160\/TH11-05-0358","volume":"106","author":"V Pengo","year":"2011","unstructured":"Pengo V, Crippa L, Falanga A et al (2011) Questions and answers on the use of dabigatran and prospectives on the use of other new oral anticoagulants in patients with atrial fibrillation. A consensus document of the Italian Federation of Thrombosis Center (FCSA). Thromb Haemost 106:868\u2013876","journal-title":"Thromb Haemost"},{"issue":"Suppl 1","key":"1877_CR10","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/jth.12227","volume":"11","author":"T Baglin","year":"2013","unstructured":"Baglin T (2013) The role of the laboratory in treatment with new oral anticoagulants. J Thromb Haemost 11 (Suppl 1):122\u2013128","journal-title":"J Thromb Haemost"},{"key":"1877_CR11","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1093\/europace\/euv309","volume":"17","author":"H Heidbuchel","year":"2015","unstructured":"Heidbuchel H, Verhamme P, Alings M et al (2015) Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace 17:1467\u20131507","journal-title":"Europace"},{"key":"1877_CR12","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1111\/bjh.12975","volume":"166","author":"S Kitchen","year":"2014","unstructured":"Kitchen S, Gray E, Mackie I, Baglin T et al (2014) Measurement of non-coumarin anticoagulants and their effects on test of haemostasis: guidance from the British Committee for Standards in Haematology. Br J Haematol 166:830\u2013841","journal-title":"Br J Haematol"},{"key":"1877_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-018-1854-6","author":"A Tripodi","year":"2018","unstructured":"Tripodi A, Marongiu F, Moia M et al (2018) The vexed question of whether or not to measure levels of direct oralanticoagulants before surgery or invasive procedures. Intern Emerg Med. \n                    https:\/\/doi.org\/10.1007\/s11739-018-1854-6\n                    \n                   (Epub ahead of print)","journal-title":"Intern Emerg Med"},{"key":"1877_CR14","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1182\/blood-2014-03-563577","volume":"124","author":"J Beyer-Westendorf","year":"2014","unstructured":"Beyer-Westendorf J, F\u00f6rster K, Pannach S et al (2014) Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry. Blood 124:955\u2013962","journal-title":"Blood"},{"key":"1877_CR15","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1056\/NEJMoa1502000","volume":"373","author":"CV Pollack Jr","year":"2015","unstructured":"Pollack CV Jr, Reilly PA, Eikelboom J et al (2015) Idarucizumab for dabigatran reversal. N Engl J Med 373:511\u2013520","journal-title":"N Engl J Med"},{"key":"1877_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40264-015-0357-x","volume":"39","author":"S Husted","year":"2016","unstructured":"Husted S, Verheugt FW, Comuth WJ (2016) Reversal strategies for NOACs: state of development, possible clinical applications and future perspectives. Drug Saf 39:5\u201313","journal-title":"Drug Saf"},{"key":"1877_CR17","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1056\/NEJMoa1607887","volume":"375","author":"SJ Connolly","year":"2016","unstructured":"Connolly SJ, Milling TJ Jr, Eikelboom JW, ANNEXA-4 Investigators et al (2016) Andexanet Alfa for acute major bleeding associated with factor Xa inhibitors. N Engl J Med 375:1131\u20131141","journal-title":"N Engl J Med"},{"issue":"371","key":"1877_CR18","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1056\/NEJMc1411800","volume":"2014","author":"JE Ansell","year":"2014","unstructured":"Ansell JE, Bakhru SH, Laulicht BE et al (2014) Use of PER977 to reverse the anticoagulant effect of edoxaban. N Engl J Med 2014(371):2141\u20132142","journal-title":"N Engl J Med"},{"key":"1877_CR19","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.drudis.2014.05.013","volume":"19","author":"DM Siegal","year":"2014","unstructured":"Siegal DM, Cuker A (2014) Reversal of target-specific oral anticoagulants. Drug Discov Today 19:1465\u20131470","journal-title":"Drug Discov Today"},{"key":"1877_CR20","doi-asserted-by":"publisher","first-page":"e0124719","DOI":"10.1371\/journal.pone.0124719","volume":"10","author":"E Antonucci","year":"2015","unstructured":"Antonucci E, Poli D, Tosetto A et al (2015) The Italian START-register on anticoagulation with focus on atrial fibrillation. PLoS One 10:e0124719","journal-title":"PLoS One"},{"key":"1877_CR21","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1111\/jth.13486","volume":"14","author":"S Testa","year":"2016","unstructured":"Testa S, Legnani C, Tripodi A et al (2016) Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter\/multiplatform study. J Thromb Haemost 14:2194\u20132201","journal-title":"J Thromb Haemost"},{"key":"1877_CR22","doi-asserted-by":"publisher","first-page":"345138","DOI":"10.1155\/2015\/345138","volume":"2015","author":"J Douxfils","year":"2015","unstructured":"Douxfils J, Mani H, Minet V et al (2015) Non-VKA oral anticoagulants: accurate measurement of plasma drug concentrations. Biomed Res Int 2015:345138","journal-title":"Biomed Res Int"},{"key":"1877_CR23","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"S Schulman","year":"2005","unstructured":"Schulman S, Kearon C (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 3:692\u2013694","journal-title":"J Thromb Haemost"},{"key":"1877_CR24","first-page":"61","volume":"14","author":"FI Mahoney","year":"1965","unstructured":"Mahoney FI, Barthel DW (1965) Functional evaluation: the Barthel index. Md State Med J 14:61\u201365","journal-title":"Md State Med J"},{"key":"1877_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-018-1811-4","author":"F Marongiu","year":"2018","unstructured":"Marongiu F, Barcellona D (2018) Direct oral anticoagulants: what can we learn? Intern Emerg Med. \n                    https:\/\/doi.org\/10.1007\/s11739-018-1811-4\n                    \n                   (Epub ahead of print)","journal-title":"Intern Emerg Med"},{"key":"1877_CR26","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.thromres.2015.12.001","volume":"137","author":"S Testa","year":"2015","unstructured":"Testa S, Legnani C, Pengo V et al (2015) Plasma levels of direct oral anticoagulants in real life patients with atrial fibrillation: results observed in four anticoagulation clinics. Tromb Res 137:178\u2013183","journal-title":"Tromb Res"},{"key":"1877_CR27","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ijcard.2016.11.117","volume":"227","author":"C Becattini","year":"2017","unstructured":"Becattini C, Franco L, Beyer-Westendorf J et al (2017) Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life. Int J Cardiol 227:261\u2013266","journal-title":"Int J Cardiol"},{"key":"1877_CR28","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1055\/s-0033-1357506","volume":"39","author":"R Veltkamp","year":"2013","unstructured":"Veltkamp R, Rizos T, Horstmann S (2013) Intracerebral bleeding in patients on antithrombotic agents. Semin Thromb Hemost 39:963\u2013971","journal-title":"Semin Thromb Hemost"},{"key":"1877_CR29","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1161\/STROKEAHA.108.520668","volume":"39","author":"B Cucchiara","year":"2008","unstructured":"Cucchiara B, Messe S, Sansing L et al (2008) Hematoma growth in oral anticoagulant related intracerebral hemorrhage. Stroke 39:2993\u20132996","journal-title":"Stroke"},{"key":"1877_CR30","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1056\/NEJMe1506600","volume":"373","author":"KA Bauer","year":"2015","unstructured":"Bauer KA (2015) Targeted anti-anticoagulants. N Engl J Med 373:569\u2013571","journal-title":"N Engl J Med"},{"key":"1877_CR31","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1161\/CIRCULATIONAHA.116.022307","volume":"134","author":"JI Weitz","year":"2016","unstructured":"Weitz JI, Eikelboom JW (2016) Urgent need to measure effects of direct oral anticoagulants. Circulation 134:186\u2013188","journal-title":"Circulation"},{"key":"1877_CR32","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/jth.13227","volume":"14","author":"JH Levy","year":"2016","unstructured":"Levy JH, Ageno W, Chan NC et al (2016) When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH. J Thromb Haemost 14:623\u2013627","journal-title":"J Thromb Haemost"},{"key":"1877_CR33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.chest.2017.02.009","volume":"152","author":"Y Xu","year":"2017","unstructured":"Xu Y, Schulman S, Dowlatshahi D et al (2017) Direct oral anticoagulant- or warfarin-related major bleeding: characteristics, reversal strategies and outcomes from a multi-center observational study. Chest 152:81\u201391","journal-title":"Chest"},{"key":"1877_CR34","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1212\/WNL.0000000000003886","volume":"88","author":"D Wilson","year":"2017","unstructured":"Wilson D, Seiffge DJ, Traenka C et al (2017) Outcome of intracerebral hemorrhage associated with different oral anticoagulants. Neurology 88:1693\u20131700","journal-title":"Neurology"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11739-018-1877-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-018-1877-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-018-1877-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T12:02:14Z","timestamp":1558526534000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11739-018-1877-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,22]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["1877"],"URL":"https:\/\/doi.org\/10.1007\/s11739-018-1877-z","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,22]]},"assertion":[{"value":"8 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The Authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional or national research committee and with the 1964 Helsinki Declaration, and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human and animal rights"}},{"value":"All patients enrolled in the study have read and signed the informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}